Quick Answer
INTERPACE BIOSCIENCES, INC. reported R&D Expense of $642.0 thousand for fiscal year 2025.
INTERPACE BIOSCIENCES, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $642.0K | -5.0% |
| 2024 | $676.0K | +6.3% |
| 2023 | $636.0K | -9.5% |
| 2022 | $703.0K | -52.9% |
| 2021 | $1.49M | -46.6% |
| 2020 | $2.79M | -0.5% |
| 2019 | $2.81M | +32.3% |
| 2018 | $2.12M | +45.4% |
| 2017 | $1.46M | -11.3% |
| 2016 | $1.65M | -28.1% |
| 2015 | $2.29M | +798.8% |
| 2014 | $255.0K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $150.0K | -24.6% | -13.3% |
| June 30, 2025 | $173.0K | +18.5% | -2.3% |
| March 31, 2025 | $177.0K | +29.2% | -11.1% |
| September 30, 2024 | $199.0K | +33.6% | +36.3% |
| June 30, 2024 | $146.0K | -21.5% | +6.6% |
| March 31, 2024 | $137.0K | -8.1% | -8.1% |
| September 30, 2023 | $149.0K | -22.0% | -19.9% |
| June 30, 2023 | $186.0K | -8.8% | +24.8% |
- INTERPACE BIOSCIENCES, INC. showed a decrease of -5.0% in R&D Expense compared to the prior fiscal year.
- Over the 2014–2025 period, INTERPACE BIOSCIENCES, INC.’s r&d expense has grown by 151.8% (from $255.0 thousand to $642.0 thousand).
- The most recent figure is from INTERPACE BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: